HIV incidence and its associated factors among young adults with multiple sexual partners in Maputo, Mozambique: a vaccine preparedness study.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
02 Oct 2024
Historique:
received: 29 12 2023
accepted: 10 09 2024
medline: 3 10 2024
pubmed: 3 10 2024
entrez: 2 10 2024
Statut: epublish

Résumé

Sub-Saharan Africa has a high burden of HIV, particularly among female sex workers (FSW) and men who have sex with men (MSM). Future clinical trials to evaluate vaccines and other interventions to prevent HIV will need to enroll populations with high HIV incidence. We conducted an observational study of HIV incidence among men and women with multiple sexual partners-including MSM and FSW-in Maputo, Mozambique, in order to prepare the country to conduct future efficacy trials of candidate HIV vaccines and other HIV prevention products. We conducted a prospective observational HIV incidence study in Maputo, Mozambique, that enrolled adults aged 18-35 years, without HIV, who had two or more sexual partners in the preceding three months. Recruitment strategies prioritized participation of MSM and FSW. Participants were followed for 24 months with HIV-1 testing every 3 months and staff-administered behavioral questionnaires every 6 months. Cox proportional hazard modeling was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for factors potentially associated with HIV acquisition. From January 2014 to October 2017, 505 adults without HIV were enrolled with median age of 21 years (interquartile range:19-24); 41% were female and 82% were single. There were 19 HIV seroconversions (10 female and 9 male) during 943 person-years (PY) of observation (overall HIV incidence 2.02/100PY; 95%CI 1.21-3.15). The highest HIV incidence was observed among sex workers (2.08/100PY; 95%CI 0.25-7.52) and MSM (19.18/100PY; 95%CI 3.96-56.06). Increased hazard of incident HIV was observed among participants who were MSM (HR = 27.95, 95%CI 4.39-117.94), p = 0.0004), reported three or more sexual partners at enrollment (HR = 7.39, 95%CI 1.64-33.25, p = 0.009), and indicated ever having a sexual partner living with HIV (HR = 9.64, 95%CI 2.23-41.71, p = 0.002). Our findings may inform inclusion criteria for upcoming clinical trials of HIV prevention interventions, including vaccine candidates, which may prioritize enrollment of MSM, people with more than three sexual partners, and people with sexual partners who are living with HIV. These same populations are in need of further intervention to reduce HIV incidence.

Identifiants

pubmed: 39358725
doi: 10.1186/s12889-024-20032-8
pii: 10.1186/s12889-024-20032-8
doi:

Substances chimiques

AIDS Vaccines 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2692

Investigateurs

Julie Ake (J)
Khelvon Leonel Jose De Araujo (KLJ)
Igor Capitine (I)
Lígia Chambule (L)
Celso Castino (C)
Eduardo Namalango (E)
Mirna Mutombene (M)
Maria Enosse (M)
Victoria Cumbane (V)
Felisberto Facuna (F)
Zebiba Hassen (Z)
Luis Inhambizo (L)
Paulo Macamo (P)
Ferrao Mandlate (F)
José Manjate (J)
Carmélia Massingue (C)
Ana Mutola (A)
Patrícia Ramgi (P)
Gail Smith (G)

Informations de copyright

© 2024. The Author(s).

Références

Fact sheet - Latest global and regional statistics on the status of the AIDS epidemic. UNAIDS July 27, 2023 [Available from: https://www.unaids.org/en/resources/documents/2022/UNAIDS_FactSheet .
Brett-Major DM, Crowell TA, Michael NL. Prospecting for an HIV vaccine. Trop Dis Travel Med Vacc. 2017;3:6.
doi: 10.1186/s40794-017-0050-4
Dangerous Inequalities. Geneva: Joint United Nationa Programme on HIV/AIDS; 2022.  https://www.unaids.org/sites/default/files/media_asset/dangerous-inequalities_en.pdf .
UNAIDS Data 2021. Geneva: Joint United Nations Programme on HIV/AIDS; 2021. https://www.unaids.org/sites/default/files/media_asset/JC3032_AIDS_Data_book_2021_En.pdf .
Viegas EO, Tembe N, Macovela E, Goncalves E, Augusto O, Ismael N, et al. Incidence of HIV and the prevalence of HIV, hepatitis B and syphilis among youths in Maputo, Mozambique: a cohort study. PLoS ONE. 2015;10(3):e0121452.
doi: 10.1371/journal.pone.0121452 pubmed: 25798607 pmcid: 4370560
De Schacht C, Mabunda N, Ferreira OC, Ismael N, Calu N, Santos I, et al. High HIV incidence in the postpartum period sustains vertical transmission in settings with generalized epidemics: a cohort study in Southern Mozambique. J Int AIDS Soc. 2014;17(1):18808.
doi: 10.7448/IAS.17.1.18808 pubmed: 24629842 pmcid: 3946505
Dubé K, Zango A, van de Wijgert J, Meque I, Ferro JJ, Cumbe F, et al. HIV incidence in a cohort of women at higher risk in Beira, Mozambique: prospective study 2009–2012. PLoS ONE. 2014;9(1):e84979.
doi: 10.1371/journal.pone.0084979 pubmed: 24475035 pmcid: 3903474
Macicame I, Bhatt N, Matavele Chissumba R, Eller LA, Viegas E, Araújo K, et al. HIV prevalence and risk behavior among male and female adults screened for enrolment into a vaccine preparedness study in Maputo, Mozambique. PLoS ONE. 2019;14(9):e0221682.
doi: 10.1371/journal.pone.0221682 pubmed: 31527868 pmcid: 6748437
Joshi K, Lessler J, Olawore O, Loevinsohn G, Bushey S, Tobian AAR, et al. Declining HIV incidence in sub-Saharan Africa: a systematic review and meta-analysis of empiric data. J Int AIDS Soc. 2021;24(10):e25818.
doi: 10.1002/jia2.25818 pubmed: 34672104 pmcid: 8528667
Price MA, Rida W, Mwangome M, Mutua G, Middelkoop K, Roux S, et al. Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth. J Acquir Immune Defic Syndr. 2012;59(2):185–93.
doi: 10.1097/QAI.0b013e31823d8693 pubmed: 22227488
Nowak RG, Mitchell A, Crowell TA, Liu H, Ketende S, Ramadhani HO, et al. Individual and sexual network predictors of HIV incidence among men who have sex with men in Nigeria. J Acquir Immune Defic Syndr. 2019;80(4):444–53.
doi: 10.1097/QAI.0000000000001934 pubmed: 30550487 pmcid: 6519125
Sanders EJ, Okuku HS, Smith AD, Mwangome M, Wahome E, Fegan G, et al. High HIV-1 incidence, correlates of HIV-1 acquisition, and high viral loads following seroconversion among MSM. AIDS. 2013;27(3):437–46.
doi: 10.1097/QAD.0b013e32835b0f81 pubmed: 23079811
Sandfort TGM, Mbilizi Y, Sanders EJ, Guo X, Cummings V, Hamilton EL, et al. HIV incidence in a multinational cohort of men and transgender women who have sex with men in sub-Saharan Africa: findings from HPTN 075. PLoS ONE. 2021;16(2):e0247195.
doi: 10.1371/journal.pone.0247195 pubmed: 33630925 pmcid: 7906338
Sullivan PS, Phaswana-Mafuya N, Baral SD, Valencia R, Zahn R, Dominguez K, et al. HIV prevalence and incidence in a cohort of South African men and transgender women who have sex with men: the sibanye methods for prevention packages programme (MP3) project. J Int AIDS Soc. 2020;23 Suppl 6(Suppl 6):e25591.
doi: 10.1002/jia2.25591 pubmed: 33000918
Lane T, Osmand T, Marr A, Struthers H, McIntyre JA, Shade SB. Brief report: high HIV incidence in a South African community of men who have sex with men: results from the Mpumalanga men’s study, 2012–2015. J Acquir Immune Defic Syndr. 2016;73(5):609–11.
doi: 10.1097/QAI.0000000000001162 pubmed: 27851715
Birdthistle I, Tanton C, Tomita A, de Graaf K, Schaffnit SB, Tanser F, et al. Recent levels and trends in HIV incidence rates among adolescent girls and young women in ten high-prevalence African countries: a systematic review and meta-analysis. Lancet Glob Health. 2019;7(11):e1521–40.
doi: 10.1016/S2214-109X(19)30410-3 pubmed: 31607465 pmcid: 7025003
Feldblum PJ, Enosse S, Dubé K, Arnaldo P, Muluana C, Banze R, et al. HIV prevalence and incidence in a cohort of women at higher risk for HIV acquisition in Chókwè, southern Mozambique. PLoS ONE. 2014;9(5):e97547.
doi: 10.1371/journal.pone.0097547 pubmed: 24842811 pmcid: 4026130
Birdthistle I, Kwaro D, Shahmanesh M, Baisley K, Khagayi S, Chimbindi N, et al. Evaluating the impact of DREAMS on HIV incidence among adolescent girls and young women: a population-based cohort study in Kenya and South Africa. PLoS Med. 2021;18(10):e1003837.
doi: 10.1371/journal.pmed.1003837 pubmed: 34695112 pmcid: 8880902

Auteurs

Ivalda Macicame (I)

Instituto Nacional de Saúde, Ministério da Saúde, Maputo, Mozambique.

Nilesh Bhatt (N)

Instituto Nacional de Saúde, Ministério da Saúde, Maputo, Mozambique.

Edna Viegas (E)

Instituto Nacional de Saúde, Ministério da Saúde, Maputo, Mozambique.

Adam Yates (A)

U.S. Military HIV Research Program, CIDR, Walter Reed Army Institute of Research, 6720A Rockledge Drive, Suite 400 Silver Spring, Bethesda, MD, 20817, USA.
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.

Chiaka Nwoga (C)

U.S. Military HIV Research Program, CIDR, Walter Reed Army Institute of Research, 6720A Rockledge Drive, Suite 400 Silver Spring, Bethesda, MD, 20817, USA.
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.

Raquel Matavele Chissumba (RM)

Instituto Nacional de Saúde, Ministério da Saúde, Maputo, Mozambique.

Vanessa Monteiro (V)

Instituto Nacional de Saúde, Ministério da Saúde, Maputo, Mozambique.

Michelle Imbach (M)

U.S. Military HIV Research Program, CIDR, Walter Reed Army Institute of Research, 6720A Rockledge Drive, Suite 400 Silver Spring, Bethesda, MD, 20817, USA.
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.

Mark Milazzo (M)

U.S. Military HIV Research Program, CIDR, Walter Reed Army Institute of Research, 6720A Rockledge Drive, Suite 400 Silver Spring, Bethesda, MD, 20817, USA.
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.

Qun Li (Q)

U.S. Military HIV Research Program, CIDR, Walter Reed Army Institute of Research, 6720A Rockledge Drive, Suite 400 Silver Spring, Bethesda, MD, 20817, USA.
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.

Steven Schech (S)

U.S. Military HIV Research Program, CIDR, Walter Reed Army Institute of Research, 6720A Rockledge Drive, Suite 400 Silver Spring, Bethesda, MD, 20817, USA.
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.

Tsedal Mebrahtu (T)

U.S. Military HIV Research Program, CIDR, Walter Reed Army Institute of Research, 6720A Rockledge Drive, Suite 400 Silver Spring, Bethesda, MD, 20817, USA.
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.

Leigh Anne Eller (LA)

U.S. Military HIV Research Program, CIDR, Walter Reed Army Institute of Research, 6720A Rockledge Drive, Suite 400 Silver Spring, Bethesda, MD, 20817, USA.
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.

Edith Swann (E)

Division of AIDS, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA.

Nelson L Michael (NL)

U.S. Military HIV Research Program, CIDR, Walter Reed Army Institute of Research, 6720A Rockledge Drive, Suite 400 Silver Spring, Bethesda, MD, 20817, USA.

Merlin L Robb (ML)

U.S. Military HIV Research Program, CIDR, Walter Reed Army Institute of Research, 6720A Rockledge Drive, Suite 400 Silver Spring, Bethesda, MD, 20817, USA.
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.

Trevor A Crowell (TA)

U.S. Military HIV Research Program, CIDR, Walter Reed Army Institute of Research, 6720A Rockledge Drive, Suite 400 Silver Spring, Bethesda, MD, 20817, USA. tcrowell@hivresearch.org.
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA. tcrowell@hivresearch.org.

Christina S Polyak (CS)

U.S. Military HIV Research Program, CIDR, Walter Reed Army Institute of Research, 6720A Rockledge Drive, Suite 400 Silver Spring, Bethesda, MD, 20817, USA.
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.

Ilesh Jani (I)

Instituto Nacional de Saúde, Ministério da Saúde, Maputo, Mozambique.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH